Anatara Lifesciences Ltd's (ASX:ANR) lead human health product, GaRP, is being developed to specifically target two human gastrointestinal (GI) disorders, Inflammatory Bowel Disease (IBD) and Irritable Bowel Syndrome (IBS), where there is a significant unmet medical need.
Bluechiip Ltd (BCT.AX) Open Briefing interview with MD Andrew McLellan where Andrew discusses the last quarter of revenue and new developments.
Bluechiip Ltd (ASX:BCT) recorded net sales revenue of $103k and sales receipts of $441k for the quarter, attributable to the sales of chips, readers, software and services.
Cann Global Ltd (ASX:CGB) ("CGB" or "the Company") presents the annual report on activities for the year ending 30 June 2019.
Regeneus Ltd (ASX:RGS) (Regeneus or the Company), a clinical-stage regenerative medicine company, releases its financial results for the financial year ended 30 June 2019 (FY2019).
MMJ Group Holdings Limited (ASX:MMJ) (FRA:2P9) (OTCMKTS:MMJJF), an Australian-listed company that specialises in managing a portfolio of investments along the cannabis value-chain, has invested CAD6m in the Canadian-listed company WeedMD Inc.
Global technology company Zoono Group Limited (ASX:ZNO) is pleased to announce that it has signed a new sales and distribution agreement in China. The agreement is with Guangzhou Sanchengyun Trade Co., Ltd for the sale of Zoono branded products online in China.
